Goldman Sachs Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Raises Target Price to $22

Futu NewsJan 14 23:31 · Ratings

Truist Financial Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating

Futu NewsJan 14 20:31 · Ratings

Iovance Biotherapeutics (IOVA) Gets a Buy From Truist Financial

TipRanksJan 14 20:17 · Ratings

Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Simply Wall StJan 14 18:34

Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsJan 13 19:31 · Ratings

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Vir Biotechnology (VIR)

TipRanksJan 12 20:40 · Ratings